Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sangamo Therapeutics (SGMO) Other Operating Expenses (2023 - 2024)

Historic Other Operating Expenses for Sangamo Therapeutics (SGMO) over the last 3 years, with Q2 2024 value amounting to $1.2 million.

  • Sangamo Therapeutics' Other Operating Expenses fell 9771.75% to $1.2 million in Q2 2024 from the same period last year, while for Mar 2025 it was $1.2 million, marking a year-over-year decrease of 9883.72%. This contributed to the annual value of $5.5 million for FY2024, which is 9643.84% down from last year.
  • As of Q2 2024, Sangamo Therapeutics' Other Operating Expenses stood at $1.2 million, which was down 9771.75% from $4.3 million recorded in Q1 2024.
  • In the past 5 years, Sangamo Therapeutics' Other Operating Expenses ranged from a high of $58.6 million in Q1 2023 and a low of $296000.0 during Q4 2023